ArticleCell stem cell2014
Identifiability and privacy in pluripotent stem cell research.
Article in Cell stem cell, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed.
- Guidelines for managing and using the digital phenotypes of pluripotent stem cell lines.Stem cell reports · 2024Review
- Facilitating the ethical sourcing of donor hematopoietic stem cells for cell and gene therapy research and development.Regenerative medicine · 2024Article
- Developing Policy for the Healthy Life Trajectories Initiative: Going from National to International.Biopreservation and biobanking · 2023Article
- Recommendations, guidelines, and best practice for the use of human induced pluripotent stem cells for neuropharmacological studies of neuropsychiatric disorders.Neuroscience applied · 2023Review
- Identification and Re-consent of Existing Cord Blood Donors for Creation of Induced Pluripotent Stem Cell Lines for Potential Clinical Applications.Stem cells translational medicine · 2022Article
- Manufacturing with pluripotent stem cells (PSConf 2021): Key issues for future research and development.Cell proliferation · 2022Article
- EBiSC best practice: How to ensure optimal generation, qualification, and distribution of iPSC lines.Stem cell reports · 2021Review
- ISSCR Guidelines for Stem Cell Research and Clinical Translation: The 2021 update.Stem cell reports · 2021Review
- Short tandem repeat profiling for the authentication of cancer stem-like cells.International journal of cancer · 2021Article
- Content and Method of Information for Participants in Clinical Studies With Induced Pluripotent Stem Cells (iPSCs).Frontiers in cell and developmental biology · 2021Article
- Donor information in research and drug evaluation with induced pluripotent stem cells (iPSCs).Stem cell research & therapy · 2020Review
- A Standard Nomenclature for Referencing and Authentication of Pluripotent Stem Cells.Stem cell reports · 2018Review
- Report of the International Stem Cell Banking Initiative Workshop Activity: Current Hurdles and Progress in Seed-Stock Banking of Human Pluripotent Stem Cells.Stem cells translational medicine · 2017Article
- The European General Data Protection Regulation: challenges and considerations for iPSC researchers and biobanks.Regenerative medicine · 2017Article
- hPSCreg--the human pluripotent stem cell registry.Nucleic acids research · 2016Article
- Ethical Issues for Clinical Studies That use Human Embryonic Stem Cells: The 2014 Revisions to the Japanese Guidelines.Stem cell reviews and reports · 2015Review
- The DISCUSS Project: Revised Points to Consider for the Derivation of Induced Pluripotent Stem Cell Lines From Previously Collected Research Specimens.Stem cells translational medicine · 2015Review
- Genetic research on biospecimens poses minimal risk.Trends in genetics : TIG · 2015Review
- Regulatory insight into the European human pluripotent stem cell registry.Stem cells and development · 2014Article
- If Human Brain Organoids Are the Answer to Understanding Dementia, What Are the Questions?The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatryReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
20 authors.
Funding
Abstract
Data sharing is an essential element of research; however, recent scientific and social developments have challenged conventional methods for protecting privacy. Here we provide guidance for determining data sharing thresholds for human pluripotent stem cell research aimed at a wide range of stakeholders, including research consortia, biorepositories, policy-makers, and funders.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.